Vancomycin in the treatment of methicillin-resistantStaphylococcus aureus– a clinician’s guide to the science informing current practice
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vancomycin in the treatment of methicillin-resistantStaphylococcus aureus– a clinician’s guide to the science informing current practice
Authors
Keywords
-
Journal
Expert Review of Anti-Infective Therapy
Volume 13, Issue 7, Pages 855-869
Publisher
Informa UK Limited
Online
2015-05-07
DOI
10.1586/14787210.2015.1041924
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Results of the Surveillance of Tedizolid Activity and Resistance Program: in vitro susceptibility of Gram-positive pathogens collected in 2011 and 2012 from the United States and Europe
- (2015) Daniel F. Sahm et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Ceftaroline-Heteroresistant Staphylococcus aureus
- (2014) Stephanie N. Saravolatz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Phase 3 Randomized Double-Blind Comparison of Ceftobiprole Medocaril Versus Ceftazidime Plus Linezolid for the Treatment of Hospital-Acquired Pneumonia
- (2014) S. S. Awad et al. CLINICAL INFECTIOUS DISEASES
- Antimicrobial Salvage Therapy for Persistent Staphylococcal Bacteremia Using Daptomycin Plus Ceftaroline
- (2014) George Sakoulas et al. CLINICAL THERAPEUTICS
- Linezolid update: Stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms
- (2014) Rodrigo E. Mendes et al. DRUG RESISTANCE UPDATES
- New pharmacological treatments for methicillin-resistantStaphylococcus aureusinfections
- (2014) Stuart L Burke et al. EXPERT OPINION ON PHARMACOTHERAPY
- Dissecting Vancomycin-Intermediate Resistance in Staphylococcus aureus Using Genome-Wide Association
- (2014) Md Tauqeer Alam et al. Genome Biology and Evolution
- Randomized non-inferiority trial to compare trimethoprim/sulfamethoxazole plus rifampicin versus linezolid for the treatment of MRSA infection
- (2014) S. Harbarth et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Single-Dose Oritavancin in the Treatment of Acute Bacterial Skin Infections
- (2014) G. Ralph Corey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transferable Vancomycin Resistance in a Community-Associated MRSA Lineage
- (2014) Flávia Rossi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Once-Weekly Dalbavancin versus Daily Conventional Therapy for Skin Infection
- (2014) Helen W. Boucher et al. NEW ENGLAND JOURNAL OF MEDICINE
- The evolution of vancomycin intermediate Staphylococcus aureus (VISA) and heterogenous-VISA
- (2013) Benjamin P. Howden et al. INFECTION GENETICS AND EVOLUTION
- Ceftaroline for meticillin-resistant Staphylococcus aureus bacteraemia: Case series and review of the literature
- (2013) Hari M. Polenakovik et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Tedizolid Phosphate vs Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections
- (2013) Philippe Prokocimer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Evaluation of Vancomycin Susceptibility Testing for Methicillin-Resistant Staphylococcus aureus: Comparison of Etest and Three Automated Testing Methods
- (2013) M. J. Rybak et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Report of the 13th Vancomycin-Resistant Staphylococcus aureus Isolate from the United States
- (2013) B. M. Limbago et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Alternative Mutational Pathways to Intermediate Resistance to Vancomycin in Methicillin-Resistant Staphylococcus aureus
- (2013) Celine Vidaillac et al. JOURNAL OF INFECTIOUS DISEASES
- Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus
- (2013) George Sakoulas et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- First case of infection with vancomycin-resistant Staphylococcus aureus in Europe
- (2013) José Melo-Cristino et al. LANCET
- Immune modulation by multifaceted cationic host defense (antimicrobial) peptides
- (2013) Ashley L Hilchie et al. Nature Chemical Biology
- Transferable Plasmid-Mediated Resistance to Linezolid Due tocfrin a Human Clinical Isolate of Enterococcus faecalis
- (2012) Lorena Diaz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- β-Lactams Increase the Antibacterial Activity of Daptomycin against Clinical Methicillin-Resistant Staphylococcus aureus Strains and Prevent Selection of Daptomycin-Resistant Derivatives
- (2012) Shrenik Mehta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Mutation in the PP2C Phosphatase Gene in a Staphylococcus aureus USA300 Clinical Isolate with Reduced Susceptibility to Vancomycin and Daptomycin
- (2012) Karla D. Passalacqua et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Clinical Significance of Vancomycin Minimum Inhibitory Concentration in Staphylococcus aureus Infections: A Systematic Review and Meta-analysis
- (2012) S. J. van Hal et al. CLINICAL INFECTIOUS DISEASES
- Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study
- (2012) R. G. Wunderink et al. CLINICAL INFECTIOUS DISEASES
- A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneumonia requiring hospitalisation
- (2012) Susan C. Nicholson et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Mechanisms of Linezolid Resistance among Staphylococci in a Tertiary Hospital
- (2012) Inmaculada Quiles-Melero et al. JOURNAL OF CLINICAL MICROBIOLOGY
- The RpoB H481Y Rifampicin Resistance Mutation and an Active Stringent Response Reduce Virulence and Increase Resistance to Innate Immune Responses in Staphylococcus aureus
- (2012) Wei Gao et al. JOURNAL OF INFECTIOUS DISEASES
- Reduced Susceptibility to Host-Defense Cationic Peptides and Daptomycin Coemerge in Methicillin-Resistant Staphylococcus aureus From Daptomycin-Naive Bacteremic Patients
- (2012) N. N. Mishra et al. JOURNAL OF INFECTIOUS DISEASES
- Mutation of RNA Polymerase β Subunit (rpoB) Promotes hVISA-to-VISA Phenotypic Conversion of Strain Mu3
- (2011) Miki Matsuo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genetic Environment and Stability ofcfrin Methicillin-Resistant Staphylococcus aureus CM05
- (2011) Jeffrey B. Locke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroCross-Resistance to Daptomycin and Host Defense Cationic Antimicrobial Peptides in Clinical Methicillin-Resistant Staphylococcus aureus Isolates
- (2011) Nagendra N. Mishra et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Vancomycin: We Can't Get There From Here
- (2011) N. Patel et al. CLINICAL INFECTIOUS DISEASES
- Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
- (2011) Catherine Liu et al. CLINICAL INFECTIOUS DISEASES
- Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure
- (2011) Peter G. Kelley et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Impact of rpoB Mutations on Reduced Vancomycin Susceptibility in Staphylococcus aureus
- (2011) Yukiko Watanabe et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Antibiotic Choice May Not Explain Poorer Outcomes in Patients With Staphylococcus aureus Bacteremia and High Vancomycin Minimum Inhibitory Concentrations
- (2011) Natasha E. Holmes et al. JOURNAL OF INFECTIOUS DISEASES
- Evolution of Multidrug Resistance during Staphylococcus aureus Infection Involves Mutation of the Essential Two Component Regulator WalKR
- (2011) Benjamin P. Howden et al. PLoS Pathogens
- Ceftobiprole: A novel, broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureus
- (2010) D. G. Dauner et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- An RpoB Mutation Confers Dual Heteroresistance to Daptomycin and Vancomycin in Staphylococcus aureus
- (2010) L. Cui et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- First Report of the Multidrug Resistance Gene cfr and the Phenicol Resistance Gene fexA in a Bacillus Strain from Swine Feces
- (2010) L. Dai et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Identification and Characterization of the Multidrug Resistance Gene cfr in a Panton-Valentine Leukocidin-Positive Sequence Type 8 Methicillin-Resistant Staphylococcus aureus IVa (USA300) Isolate
- (2010) A. C. Shore et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications
- (2010) B. P. Howden et al. CLINICAL MICROBIOLOGY REVIEWS
- Community-Associated Methicillin-Resistant Staphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
- (2010) M. Z. David et al. CLINICAL MICROBIOLOGY REVIEWS
- Correlation between vancomycin and daptomycin MIC values for methicillin-susceptible and methicillin-resistant Staphylococcus aureus by 3 testing methodologies
- (2010) Rebecca A. Keel et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Clinical Outbreak of Linezolid-Resistant Staphylococcus aureus in an Intensive Care Unit
- (2010) Miguel Sánchez García JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Comparison of Detection Methods for Heteroresistant Vancomycin-Intermediate Staphylococcus aureus, with the Population Analysis Profile Method as the Reference Method
- (2010) S. W. Satola et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Two Novel Point Mutations in Clinical Staphylococcus aureus Reduce Linezolid Susceptibility and Switch on the Stringent Response to Promote Persistent Infection
- (2010) Wei Gao et al. PLoS Pathogens
- Contribution of vraSR and graSR Point Mutations to Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus
- (2009) L. Cui et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Nine-Hospital Study Comparing Broth Microdilution and Etest Method Results for Vancomycin and Daptomycin against Methicillin-Resistant Staphylococcus aureus
- (2009) H. S. Sader et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of Vancomycin and Daptomycin Potency Trends (MIC Creep) against Methicillin-Resistant Staphylococcus aureus Isolates Collected in Nine U.S. Medical Centers from 2002 to 2006
- (2009) H. S. Sader et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Prospective Comparison of the Clinical Impacts of Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Susceptible MRSA
- (2009) K. C. Horne et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health‐System Pharmacists, and the Society of Infectious Diseases Pharmacists
- (2009) Michael J. Rybak et al. CLINICAL INFECTIOUS DISEASES
- Relationship between Initial Vancomycin Concentration‐Time Profile and Nephrotoxicity among Hospitalized Patients
- (2009) Thomas P. Lodise et al. CLINICAL INFECTIOUS DISEASES
- Salvage Treatment for Persistent Methicillin‐ResistantStaphylococcus aureusBacteremia: Efficacy of Linezolid With or Without Carbapenem
- (2009) Hee‐Chang Jang et al. CLINICAL INFECTIOUS DISEASES
- Effect of vancomycin plus rifampicin in the treatment of nosocomial methicillin-resistant Staphylococcus aureus pneumonia*
- (2009) Young Ju Jung et al. CRITICAL CARE MEDICINE
- Evaluation of the Etest GRD for the detection of Staphylococcus aureus with reduced susceptibility to glycopeptides
- (2009) S. N. Leonard et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Vancomycin MICs for Staphylococcus aureus Vary by Detection Method and Have Subtly Increased in a Pediatric Population Since 2005
- (2009) E. O. Mason et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Accuracy of Commercial and Reference Susceptibility Testing Methods for Detecting Vancomycin-Intermediate Staphylococcus aureus
- (2009) J. M. Swenson et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Vancomycin MIC plus Heteroresistance and Outcome of Methicillin-Resistant Staphylococcus aureus Bacteremia: Trends over 11 Years
- (2009) A. C. Musta et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
- (2008) M. Rybak et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Addition of Rifampin to Standard Therapy for Treatment of Native Valve Infective Endocarditis Caused by Staphylococcus aureus
- (2008) D. J. Riedel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of a New Etest Vancomycin-Teicoplanin Strip for Detection of Glycopeptide-Intermediate Staphylococcus aureus (GISA), in Particular, Heterogeneous GISA
- (2008) A. Yusof et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Characterization of Vancomycin-Heteroresistant Staphylococcus aureus from the Metropolitan Area of Detroit, Michigan, over a 22-Year Period (1986 to 2007)
- (2008) M. J. Rybak et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Identification and characterization of a vancomycin-resistant Staphylococcus aureus isolated from Kolkata (South Asia)
- (2007) B. Saha et al. JOURNAL OF MEDICAL MICROBIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started